Navigation Links
Texas Hospital nation's first to use large-scale 'cocoon strategy' against whooping cough
Date:1/25/2008

Houston, TX (Jan. 24, 2008) The new Center for Vaccine Awareness and Research at Texas Childrens Hospital announced that it will implement the nations first major cocoon strategy vaccination program to protect newborn infants from the life-threatening infection pertussis, more commonly known as whooping cough.

Whooping cough is a highly-contagious bacterial infection of the respiratory system. While the disease can occur at any age, whooping cough can be particularly serious and even life-threatening to very young infants. Recent statistics show that whooping cough is on the rise again. According to the Centers for Disease Control and Prevention (CDC), over 50,000 cases of whooping cough were reported in the United States in 2004 and 2005, the largest number since the 1950s. This increase is due to an epidemic of pertussis in adolescents and adults who have lost their immunity from their childhood vaccines and need a booster vaccine. While this population has less severe consequences from the infection, they are the source of its spread to infants who are too young to be protected by their own vaccinations.

The cocoon strategy is the process of vaccinating the babys mother and other adolescent and adult family members who will be in close contact with the infant, so that the baby is surrounded by family members who can not spread pertussis. Babies under six months old are too young to have received all three doses of the whooping cough vaccine, and studies show that more than 75 percent of infected babies get pertussis from family members.

The idea behind the cocoon strategy is that the vaccinated family members can block transmission of the infection to the unvaccinated or incompletely vaccinated infant, said C. Mary Healy, M.D., program leader and director of Vaccinology and Maternal Immunization at the Center for Vaccine Awareness and Research.

Through this program, Texas Childrens Center for Vaccine Awareness and Research wi
'/>"/>

Contact: Carol Wittman
cmwittma@texaschildrenshospital.org
832-824-2040
Texas Children's Hospital
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology news :

1. Rices West honored as one of Texas best researchers
2. UT Southwestern scientist honored among best in Texas research
3. Gulf of Mexico dead zone to be studied by University of Texas at Austin marine scientists
4. Ceres and Texas A&M to develop and market high-biomass sorghum for biofuels
5. Texas researchers and educators head for Antarctica
6. Pennsylvania Hospital recognized for excellence in bariatric surgery
7. Childrens Hospital neurosurgeon receives grant
8. Pennsylvania Hospital surgeon receives grant to develop molecular cardiac surgery
9. Childrens Hospital studying drug with the potential to prevent/delay onset of type 1 diabetes
10. Nationwide Childrens Hospital involved in expanded access program for treatment of PKU
11. 3 out of 4 hospital patients suffer from malnutrition regardless of their pathology

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...is release is available in Spanish . , The ...er levels of inflammatory substances in the blood,...as shown by a research project of the University o... scientist at the School of Pharmacy. , The proj...dy in relation to the control of body weight and i...
(Date:11/23/2009)... Cambridge, Mass. November 23, 2009 Applied math...n lily ( Hosta lancifolia ), a characteristic long...y packed ripples along the edges. The simple cause...sulting from bending during differential growthwas...retching foam ribbons. , Haiyi Liang, a postdoct...
(Date:11/23/2009)...INE, Calif. -- More than 160 participants gathered...es Keck FUTURES INITIATIVE conference. This year,s...ntists, engineers, and medical researchers to expl... surrounding the emerging field of synthetic biolo...biology at Princeton University and this year,s co...
Breaking Biology News(10 mins):It can be predicted the reaction obese patients will have to a diet 2The cause behind the characteristic shape of a long leaf revealed 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2EHE International Supports The Michael J Fox Foundation for Parkinsons Research 53849 1EHE International Supports The Michael J Fox Foundation for Parkinsons Research 53849 2Curis and Debiopharm Sign an Exclusive License Agreement Covering the HSP90 Inhibitor CUDC 305 13415 1Curis and Debiopharm Sign an Exclusive License Agreement Covering the HSP90 Inhibitor CUDC 305 13415 2Curis and Debiopharm Sign an Exclusive License Agreement Covering the HSP90 Inhibitor CUDC 305 13415 3Curis and Debiopharm Sign an Exclusive License Agreement Covering the HSP90 Inhibitor CUDC 305 13415 4Curis and Debiopharm Sign an Exclusive License Agreement Covering the HSP90 Inhibitor CUDC 305 13415 5Curis and Debiopharm Sign an Exclusive License Agreement Covering the HSP90 Inhibitor CUDC 305 13415 6Cyberonics to Present at Canaccord Adams 29th Annual Global Growth Conference 53844 1Cyberonics to Present at Canaccord Adams 29th Annual Global Growth Conference 53844 2
...ALR) recently announced it will award nearly $7 mi... very proud to announce, during National Minority ... the ALR has funded more than 100 research project..., since our founding in 1999, says ALR President B...he ALRs website, www.lupusresearch.org . , Twen...
...icine have identified, characterized and cloned ov...stem cells may be the source of ovarian cancers re...hese results bring us closer to more effective and... one of the most lethal forms of cancer, said Gil ...f Obstetrics, Gynecology & Reproductive Sciences a...
...killed between 30 and 50 million people. In the in...cute respiratory distress syndrome (ARDS). This fa...ring which the lung becomes severely damaged. ARDS...ections, but also by chemical agents. These could ...en aspirated. Once ARDS has developed, survival ra...
Other Biology News:The Alliance for Lupus Research announces 2008 grantees 2Ovarian cancer stem cells identified, characterized 2New strategies against bird flu 2
(Date:11/24/2009)... The FBI recently approved the Promega PowerPl...ing in or generating DNA records for the National ...on, WI USA (PRWEB) -- The FBI recently approved th... laboratories participating in, or generating DNA ... NDIS currently contains more than seven million p...
(Date:11/24/2009)...er24/PRNewswire-FirstCall/--Shireplc(LSE:SHP,NASD...pany,today,announcedthatithassubmittedaMAAtotheEur...ny,senzymereplacementtherapyindevelopment,forthetr...ng,applicationforvelaglucerasealfathathasbeensubmi...anada. , Basedonaglobalsupplyshortageofthecur...
(Date:11/24/2009)...ovember24/PRNewswire/--HealthRoboticstodayannounce...pofselected,investors.ThisrecentlyformedToronto-ba...nada,Inc.andwillmarket,install,andsupport,HealthRo...,revolutionaryproductofferingsi.v.STATION(TM),i.v....lsoprovideassistanceonan"asneeded,basis"toitsstrat...
(Date:11/24/2009)...4/PRNewswire-FirstCall/--CellTherapeutics,Inc.(CTI...AnnualPiperJaffrayHealthCareConference.Theconferen...el. ,, CTIwillpresentonTuesday,December1at11:00...stofCTI,spresentationwillbeavailableat www.cellthe...terwards. , ,PiperJaffrayHealthCareConference,New...
Breaking Biology Technology:NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2
... , , , , , , , ,...re New to Transfection , , , Below,...ultured cells using ,FuGENE 6 is presented that ... ,new to transfection. , , , 1. ..., , , Ensure the cells are growing w...
... , , , , , , , ,...Reagent in Vector-based shRNA Experiments , ...uced by siRNAs or shRNAs allows reliable down-regu...uman and other mammalian cells. While ,siRNAs in...t gene silencing, ,vectors that encode for the i...
... , , , , , , , ,...es that can be transfected using ,currently avai... differences in ,the efficiency of DNA delivery ...ypes, such as HeLa, K-562, and Jurkat, the broad-s...sually provide relatively low transfection efficie...
Other Biology Technology:Uses and Applications of FuGENE 6 Transfection Reagent 2Uses and Applications of FuGENE 6 Transfection Reagent 3Uses and Applications of FuGENE 6 Transfection Reagent 4Uses and Applications of X-tremeGENE Q2 Transfection Reagent 2
... value of your microarray data using Asuragens bio...ed from consultation to extensive data analysis us...tise in combination with the Gene Expression Profi...ts., ,Normalization and basic statistical anal...
CORNING ROLLER BOTTLE WITH CELLBIND, 1700CM2, STERILE from Sigma-Aldrich
... (OSM) is a pleiotropic cytokine produced by activ.... OSM inhibits the growth of some tumour and norma...and Kaposis sarcoma cell proliferation, cytokine r...protein receptor expression on hepatoma cells. Mou...
...syringe pump series combines Harvard Apparatuss be...ce and a wide range of configuration options. A lo...nsions of syringes from all the major manufacturer...e pertinent information from across the lab. All m...
Biology Products: